VACCINATION SITE INFLAMMATION

VACCINATION SITE INFLAMMATION was reported 57 times

VACCINATION SITE INFLAMMATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Skin Test Antigen [EPC] 8 0.0042
1 Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] 1 0.0006
2 CD52-directed Cytolytic Antibody [EPC] 6 0.0003
3 Interleukin-17A Antagonist [EPC] 5 0.0001
4 Bile Acid [EPC] 2 0.0001
5 Antimetabolite Immunosuppressant [EPC] 1 0.0000
6 Histamine-1 Receptor Antagonist [EPC] 3 0.0000
7 Anti-IgE [EPC] 3 0.0000
8 Calcineurin Inhibitor Immunosuppressant [EPC] 3 0.0000
9 Angiotensin Converting Enzyme Inhibitor [EPC] 3 0.0000
10 Alkylating Drug [EPC] 5 0.0000
11 Complement Inhibitor [EPC] 1 0.0000
12 Interleukin-6 Receptor Antagonist [EPC] 2 0.0000
13 Tetracycline-class Drug [EPC] 1 0.0000
14 Vitamin D [EPC] 4 0.0000
15 Vitamin B12 [EPC] 4 0.0000
16 Integrin Receptor Antagonist [EPC] 1 0.0000
17 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1 0.0000
18 Atypical Antipsychotic [EPC] 5 0.0000
19 Vitamin C [EPC] 4 0.0000
20 Dihydropyridine Calcium Channel Blocker [EPC] 3 0.0000
21 Folate Analog Metabolic Inhibitor [EPC] 4 0.0000
22 HMG-CoA Reductase Inhibitor [EPC] 3 0.0000
23 Tumor Necrosis Factor Blocker [EPC] 8 0.0000
24 Corticosteroid [EPC] 10 0.0000
25 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
26 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
27 Estrogen [EPC] 1 0.0000
28 Interferon beta [EPC] 1 0.0000
29 Proton Pump Inhibitor [EPC] 3 0.0000
30 Benzodiazepine [EPC] 3 0.0000
31 Factor Xa Inhibitor [EPC] 1 0.0000
32 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
33 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000
34 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000
35 Kinase Inhibitor [EPC] 1 0.0000